Clinical Trial Update: BiRd vs. Rd as Initial Therapy in Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BiRd versus Rd as initial therapy in multiple myeloma was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BiRd
• Rd

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2023-06-05